Patterns of multimorbidity in middle-aged and elderly type 2 diabetes patients: an electronic outpatient medical record-based analysis
-
摘要:
目的 了解中老年2型糖尿病患者的共病模式和核心共病,为中医健康管理和临床治疗指南的完善提供科学依据。 方法 收集2015年1月1日 — 2019年12月31日在中国中医科学院西苑医院就诊的21425例中老年2型糖尿病患者门诊电子病历数据,采用关联规则挖掘识别2型糖尿病患者常见的二元共病模式,并构建2型糖尿病患者的共病网络,依据网络拓扑学指标判断共病网络中的核心共病。 结果 21425例中老年2型糖尿病患者中,存在共病者17843例(83.3 %);冠心病、充血性心衰、心房颤动、缺血性脑卒中、高血压、血脂异常、动脉硬化、慢性阻塞性肺疾病、哮喘、慢性肾炎、慢性肝炎、类风湿性关节炎、骨关节炎、骨质疏松、抑郁症和焦虑症等16种慢性病共形成了76个有意义的二元共病模式,以支持度排序,最常见的二元共病模式为“冠心病 + 高血压”(支持度 = 0.45,提升度 = 1.31),高血压和冠心病存在于15个二元疾病模式中;在中医就诊的中老年2型糖尿病患者中,共病网络图显示高血压、冠心病、血脂异常、骨质疏松和骨关节炎间的共患率较高,存在复杂的共患关系;共病网络中,节点度和紧密度最大的疾病为冠心病和高血压(节点度 = 15,紧密度 = 0.45);结合点度、点权、紧密度和特征向量中心性指标发现,高血压、冠心病、血脂异常、骨关节炎和骨质疏松位于网络的枢纽位置,为中老年2型糖尿病患者的核心共病。 结论 高血压、冠心病、血脂异常、骨关节炎和骨质疏松是中老年2型糖尿病患者的核心共病,患者和医疗机构应针对这些疾病进行有效预防和管理。 Abstract:Objective To identify multimorbidity patterns and major comorbidities in middle-aged and elderly patients with type 2 diabetes mellitus (T2DM) for providing evidence to the improvement of traditional Chinese health management and clinical guidelines on multimorbidity. Methods We extracted electronic medical records of 21 425 T2DM patients aged ≥ 45 years and seeking medication from January 1, 2015 to December 31, 2019 in Xiyuan Hospital of the Chinese Academy of Chinese Medical Sciences. Association rule mining was used to identify common binary patterns of multimorbidity in the patients and the multimorbidity network for the T2DM patients was constructed. The major comorbidities were identified according to the network topological index. Results Of all the T2DM patients, 83.3% (17 843) were diagnosed with 16 other chronic diseases. Among the 16 chronic diseases (including coronary heart disease, congestive heart failure, atrial fibrillation, ischemic stroke, hypertension, dyslipidemia, atherosclerosis, chronic obstructive pulmonary disease, asthma, chronic nephritis, chronic hepatitis, rheumatoid arthritis, osteoarthritis, osteoporosis, depression, and anxiety), totally 76 types of binary patterns of multimorbidity were found, with the most common comorbidity of coronary heart disease and hypertension (support index = 0.45, lift index = 1.31) according the rank of support index and hypertension and coronary heart disease being the diseases in 15 binary comorbidities. For the T2DM patients treated with traditional Chinese medicine, the multimorbidity network plot suggested higher multimorbidity rates among hypertension, coronary heart disease, dyslipidemia, osteoporosis and osteoarthritis diseases, indicating a complex multimorbidity relationship. In the multimorbidity network constructed, coronary heart disease and hypertension were identified with the greatest node and closeness degree (nodes = 15, closeness index = 0.45). Based on the degrees of node, strength, closeness and eigenvector centrality, hypertension, coronary heart disease, dyslipidemia, osteoarthritis and osteoporosis were at the key positions in the multimorbidity network constructed and were the major comorbidities among the T2DM patients. Conclusion Among middle-aged and elderly patients with type 2 diabetes mellitus, hypertension, coronary heart disease, dyslipidemia, osteoarthritis and osteoporosis are the major comorbidities and the comorbities need to be concerned for effective prevention and management on multimorbidity in the patients. -
表 1 2型糖尿病患者共病网络疾病节点拓扑学指标(依据点度排序)
疾病 点度 点权 紧密度 特征向量中心性 冠心病 15 224.63 0.45 0.46 高血压 15 217.87 0.45 0.45 血脂异常 14 203.18 0.42 0.43 骨关节炎 14 157.38 0.39 0.35 骨质疏松 14 146.14 0.38 0.32 缺血性脑卒中 13 115.50 0.36 0.26 动脉硬化 10 99.05 0.35 0.24 哮喘 8 49.06 0.27 0.12 焦虑 8 37.59 0.23 0.09 抑郁 8 32.81 0.22 0.08 慢性肝炎 7 30.13 0.22 0.08 慢性阻塞性肺疾病 7 21.57 0.17 0.05 充血性心衰 6 19.16 0.19 0.05 类风湿性关节炎 6 21.55 0.19 0.06 慢性肾炎 5 17.80 0.19 0.05 房颤 2 4.56 0.12 0.01 -
[1] Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th Edition[J]. Diabetes Research and Clinical Practice, 2019, 157: 107843. doi: 10.1016/j.diabres.2019.107843 [2] Cicek M, Buckley J, Pearson-Stuttard J, et al. Characterizing multimorbidity from type 2 diabetes: insights from clustering approaches[J]. Endocrinology and Metabolism Clinics of North America, 2021, 50(3): 531 – 558. doi: 10.1016/j.ecl.2021.05.012 [3] 邓姣, 王维斌, 陈锦明, 等. 中医健康管理在慢性病管理中的优势分析[J]. 福建中医药, 2021, 52(5): 5 – 6. doi: 10.3969/j.issn.1000-338X.2021.05.003 [4] Chen H, Zhang YY, Wu D, et al. Comorbidity in adult patients hospitalized with type 2 diabetes in Northeast China: an analysis of hospital discharge data from 2002 to 2013[J]. BioMed Research International, 2016, 2016: 1671965. [5] Gao F, Chen JG, Liu XQ, et al. Latent class analysis suggests four classes of persons with type 2 diabetes mellitus based on complica-tions and comorbidities in Tianjin, China: a cross - sectional analysis[J]. Endocrine Journal, 2017, 64(10): 1007 – 1016. doi: 10.1507/endocrj.EJ17-0199 [6] 王伽婷, 王紫荆, 武轶群, 等. 北京地区115万2型糖尿病患者常见共患疾病的流行情况及特点[J]. 第三军医大学学报, 2021, 43(12): 1126 – 1132. [7] 北京协和医院世界卫生组织疾病分类合作中心. 疾病和有关健康问题的国际统计分类 第十次修订本 第二卷[M]. 北京: 人民卫生出版社, 2001. [8] 中华人民共和国国家统计局. 中国卫生健康统计年鉴[EB/OL]. [2021 – 07 – 31 ].https://data.cnki.net/Yearbook/single/N2020020200. [9] Bragg F, Holmes MV, Iona A, et al. Association between diabetes and cause - specific mortality in rural and urban areas of China[J]. JAMA, 2017, 317(3): 280 – 289. doi: 10.1001/jama.2016.19720 [10] Lee Y, Kim H, Jeong H, et al. Patterns of multimorbidity in adults: an association rules analysis using the Korea health panel[J]. International Journal of Environmental Research and Public Health, 2020, 17(8): 2618. doi: 10.3390/ijerph17082618 [11] 喻依. 复杂网络节点重要性研究[D]. 广州: 暨南大学, 2015. [12] Nowakowska M, Zghebi SS, Ashcroft DM, et al. The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predic-tions from a large English primary care cohort[J]. BMC Medicine, 2019, 17: 145. doi: 10.1186/s12916-019-1373-y [13] 张冉, 路云, 张闪闪, 等. 中国老年人慢性病共病患病模式及疾病相关性分析[J]. 中国公共卫生, 2019, 35(8): 1003 – 1005. doi: 10.11847/zgggws1120351 [14] Zhang YQ, Jiang XL, Bo J, et al. Risk of stroke and coronary heart disease among various levels of blood pressure in diabetic and nondiabetic Chinese patients[J]. Journal of Hypertension, 2018, 36(1): 93 – 100. doi: 10.1097/HJH.0000000000001528 [15] Gruneir A, Markle-Reid M, Fisher K, et al. Comorbidity burden and health services use in community - living older adults with diabetes mellitus: a retrospective cohort study[J]. Canadian Journal of Diabetes, 2016, 40(1): 35 – 42. doi: 10.1016/j.jcjd.2015.09.002 [16] Alonso-Morán E, Orueta JF, Esteban JIF, et al. Multimorbidity in people with type 2 diabetes in the Basque country (Spain): prevalence, comorbidity clusters and comparison with other chronic patients[J]. European Journal of Internal Medicine, 2015, 26(3): 197 – 202. doi: 10.1016/j.ejim.2015.02.005 [17] Lin PJ, Kent DM, Winn A, et al. Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences[J]. The American Journal of Managed Care, 2015, 21(1): e23 – e34. [18] 杨志清, 张靓, 郭玲玲, 等. 基于数据挖掘与可视化技术的2型糖尿病疾病关联性分析[J]. 中国临床研究, 2020, 33(11): 1490 – 1494. [19] Liu SW, Li YC, Zeng XY, et al. Burden of cardiovascular diseases in China, 1990 – 2016: findings from the 2016 global burden of disease study[J]. JAMA Cardiology, 2019, 4(4): 342 – 352. doi: 10.1001/jamacardio.2019.0295 [20] Wang ZW, Chen Z, Zhang LF, et al. Status of hypertension in China: results from the China hypertension survey, 2012 – 2015[J]. Circulation, 2018, 137(22): 2344 – 2356. doi: 10.1161/CIRCULATIONAHA.117.032380 [21] 庞元捷, 余灿清, 郭彧, 等. 中国成年人行为生活方式与主要慢性病的关联 —— 来自中国慢性病前瞻性研究的证据[J]. 中华流行病学杂志, 2021, 42(3): 369 – 375. doi: 10.3760/cma.j.cn112338-20210220-00129 [22] 杨阳, 朱志鸿, 张行易, 等. 中国东北地区35 ~ 75岁成人心血管疾病高危风险特征和预防性药物使用[J]. 中国公共卫生, 2021, 37(10): 1483 – 1488. doi: 10.11847/zgggws1133293 [23] Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardio-vascular disease: clinical insights and vascular mechanisms[J]. The Canadian Journal of Cardiology, 2018, 34(5): 575 – 584. doi: 10.1016/j.cjca.2017.12.005 [24] 刘超. 糖尿病患者心血管疾病发病机制的研究进展[J]. 医学综述, 2015, 21(1): 103 – 105. doi: 10.3969/j.issn.1006-2084.2015.01.040 [25] 杨宗璐, 柯亭羽. 糖尿病并发心血管疾病的研究进展[J]. 中国老年保健医学, 2021, 19(1): 92 – 94,98. [26] Si YH, Wang CY, Guo Y, et al. Prevalence of osteoporosis in patients with type 2 diabetes mellitus in the Chinese mainland: a systematic review and meta - analysis[J]. Iranian Journal of Public Health, 2019, 48(7): 1203 – 1214. [27] Sun XS, Zhen XM, Hu XQ, et al. Osteoarthritis in the middle - aged and elderly in China: prevalence and influencing factors[J]. International Journal of Environmental Research and Public Health, 2019, 16(23): 4701. doi: 10.3390/ijerph16234701 [28] Rehling T, Bjørkman ASD, Andersen MB, et al. Diabetes is associated with musculoskeletal pain, osteoarthritis, osteoporosis, and rheumatoid arthritis[J]. Journal of Diabetes Research, 2019, 2019: 6324348. [29] Napoli N, Chandran M, Pierroz DD, et al. Mechanisms of diabetes mellitus - induced bone fragility[J]. Nature Reviews Endocrinology, 2017, 13(4): 208 – 219. doi: 10.1038/nrendo.2016.153 [30] Cannata F, Vadalà G, Ambrosio L, et al. Osteoarthritis and type 2 diabetes: from pathogenetic factors to therapeutic intervention[J]. Diabetes/Metabolism Research and Reviews, 2020, 36(3): e3254.